Atc Pharma Private Limited - Due diligence report

A 360° intelligence report on Atc Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and dist…

2019-01-22 Balanagar, Telangana Amalgamated Unlisted Active Compliant
Share
Connect MCP
AP Atc Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Atc Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
48/100
Trust Score
Caution Indicated

Atc Pharma Private Limited is assessed as Caution Indicated with a Trust Score of 48/100. Atc Pharma Private Limited is a private limited indian non-government company incorporated in 2019, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.

Report generated on 04 Oct 2026 from the latest processed filings. Atc Pharma Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
48/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
16/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
25/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 1.42).
  • Externally credit-rated (A).

Charges position: 0 open (-) · 1 satisfied (36.00 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited1 48.0 cr
Compliance Score: 16/100 Caution Indicated
  • Company status is "Amalgamated" - not Active.
  • Last balance sheet is for Mar 2023 - filings overdue.
  • Litigation present in 2 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
ARVIND KUMAR VENKAT 01234567 Director 01/04/2018 6 yrs Approved
RUPESH HEMENDRA SHAH 01234567 Director 01/04/2018 6 yrs Approved
FIROZ PATEL 01234567 Director 01/04/2018 6 yrs Approved
SABIR MOHMADBHAI PATEL 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2022)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Dhruvi Pharma Private Limited
Subsidiaries
1
Group entities
1
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Atc Medicare Private Limited Subsidiary Company 74.00%
Dhruvi Pharma Private Limited Holding Company 74.00%
Keimed Private Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 25
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Operating for 7 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Statutory filings appear overdue.
Adverse company status: Amalgamated.
Compliance score is weak (16/100).
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence28/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 4 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment60/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view58/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 11 events
31 Aug 2023
Last AGM held
Annual general meeting
03 Aug 2023
Charge satisfied
Hdfc Bank Limited
31 Mar 2023
Latest balance sheet
Filed with ROC
20 Mar 2023
Director ceased
ARVIND KUMAR VENKAT
Director ceased
RUPESH HEMENDRA SHAH
08 Aug 2019
Charge created
Hdfc Bank Limited - 36.00 cr
18 May 2019
Director appointed
ARVIND KUMAR VENKAT (Nominee Director)
Director appointed
RUPESH HEMENDRA SHAH (Nominee Director)
22 Jan 2019
Incorporated
Registered with Roc Hyderabad
Director appointed
FIROZ PATEL (Director)
Director appointed
SABIR MOHMADBHAI PATEL (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
4 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 1 registered charge(s) stand satisfied - past borrowings repaid.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of A from Care.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
R K Babu Trading Private Limited U52599MH2011PTC222325 Jalna, Maharashtra, India
Harting (India) Private Limited U51909TN2005PTC056009 Chennai, Tamil Nadu, India
Hemang Resources Limited L65922TN1993PLC101885 Perambur Purasawalkam, Tamil Nadu, India
K.Uttamlal (Exports) Private Limited U51900MH1971PTC014991 Mumbai, Maharashtra, India
Patnaik Steel International Limited U74999WB2011PLC161642 Kolkata, West Bengal, India
Kairali Structural Fabrication Private Limited U28113KL2008PTC022813 Ernakulam, Kerala, India
Varsiddhi Enterprises Private Limited U51900TN2008PTC067628 Chennai, Tamil Nadu, India
Indian Sugar Manufacturing Company Limited U15424PN2000PLC014353 Solapur, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Atc Pharma Private Limited before audits and certifications: compliance score 16/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Atc Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Atc Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 48/100, distress signals and MSME payment-delay disclosures - know whether Atc Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Atc Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Atc Pharma Private Limited an active company?

Atc Pharma Private Limited has MCA status “Amalgamated” with a compliance score of 16/100 (Caution Indicated).

Is Atc Pharma Private Limited financially healthy?

Atc Pharma Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Atc Pharma Private Limited?

Its overall Trust Score is 48/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Atc Pharma Private Limited?

The ultimate holding entity is Dhruvi Pharma Private Limited. 4 active director(s) are on record.

Does Atc Pharma Private Limited have loans or charges against its assets?

No open charges - all 1 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Atc Pharma Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2023 - filings overdue. Overall compliance score: 16/100 (Caution Indicated).

Is it risky to lend to Atc Pharma Private Limited?

Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.